{"abstract":"This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, exclusive license (excluding the nonexclusively licensed field of use entitled \"Use of P4 as either a carrier and/or immunoenhancer in a polysaccharide vaccine conjugate for prevention of Streptococcus pneumonia infection in humans\") to practice the inventions embodied in the patent application referred to below to Viper Therapeutics, having a place of business in Atlanta, Georgia. The patent rights in these inventions have been assigned to the government of the United States of America. The patent(s) to be licensed are:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Disease Control and Prevention","name":"Centers for Disease Control and Prevention","id":44,"url":"https://www.federalregister.gov/agencies/centers-for-disease-control-and-prevention","json_url":"https://www.federalregister.gov/api/v1/agencies/44","parent_id":221,"slug":"centers-for-disease-control-and-prevention"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/05/02/2012-10547.html","cfr_references":[],"citation":"77 FR 26014","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"5/19/2005.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-10547","effective_on":null,"end_page":26014,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/05/02/2012-10547.xml","html_url":"https://www.federalregister.gov/documents/2012/05/02/2012-10547/prospective-grant-of-exclusive-license-p4-peptide-from-streptococcus-pneumoniae","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-10547?publication_date=2012-05-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-05-02/2012-10547/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":87,"last_updated":"2026-07-25 22:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-05-02/pdf/2012-10547.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-10547.pdf?1335876446","publication_date":"2012-05-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/05/02/2012-10547.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2012-05-22T08:05:50Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":26014,"subtype":null,"title":"Prospective Grant of Exclusive License: P4 Peptide From Streptococcus Pneumoniae","toc_doc":"P4 Peptide from Streptococcus pneumoniae","toc_subject":"Prospective Grant of Exclusive Licenses:","topics":[],"type":"Notice","volume":77}